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Pandemic influenza A virus (IAV) outbreaks occur when strains from animal reservoirs
acquire the ability to infect and spread among humans. The molecular basis of this species
barrier is incompletely understood. Here we combine metabolic pulse labeling and quanti-
tative proteomics to monitor protein synthesis upon infection of human cells with a human-
and a bird-adapted IAV strain and observe striking differences in viral protein synthesis. Most
importantly, the matrix protein M1 is inefficiently produced by the bird-adapted strain. We
show that impaired production of M1 from bird-adapted strains is caused by increased
splicing of the M segment RNA to alternative isoforms. Strain-specific M segment splicing is
controlled by the 3′ splice site and functionally important for permissive infection. In silico and
biochemical evidence shows that avian-adapted M segments have evolved different con-
served RNA structure features than human-adapted sequences. Thus, we identify M segment
RNA splicing as a viral host range determinant.
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Influenza A viruses (IAVs) are negative-sense, single-strandedRNA viruses with a segmented genome. IAV infection causesseasonal epidemics and sporadically pandemic outbreaks in
the human population with significant morbidity, mortality, and
economic burden. IAVs can infect both mammals (e.g., humans,
pigs, horses) and birds (e.g., chicken, waterfowl). However, strains
that are replicating in birds typically do not infect mammals and
vice versa. Pandemics occur when influenza strains of avian
origin with novel antigenicity acquire the ability to transmit
among humans1. Understanding the molecular basis of host
specificity is therefore of high medical relevance.
The species barriers that hinder most avian IAVs from suc-
cessfully infecting humans are effective at several steps in the viral
life cycle. For example, the avian virus receptor hemagglutinin
(HA) recognizes oligosaccharides containing terminal sialic acid
(SA) that are linked to galactose by α2,32. In the human upper
respiratory airway epithelium, the dominant linkage is of α2,6
type, to which human-adapted HA binds. Despite these differ-
ences in receptor binding, many avian viruses are internalized by
human cells and initiate expression of the viral genome. Such
infections typically lead to an abortive, nonproductive outcome in
mammalian cell lines. Our understanding of this intracellular
restriction is still incomplete. One well-established factor is the
influenza RNA-dependent RNA polymerase (RdRP): this enzyme
catalyzes replication of the viral genome and transcription of viral
messenger RNAs (mRNAs)3. Polymerases from avian strains are
considerably less active in mammalian cells than their counter-
parts from mammalian-adapted strains4. A wealth of experi-
mental data described adaptive mutations that alter receptor
specificity or fusion activity of HA (reviewed in ref. 5) and
polymerase activity (reviewed in ref. 6). However, relatively little
is known about the contribution of other IAV genes for per-
missive vs. non-permissive infection7.
A crucial aspect for permissive infection is the correct timing of
viral gene expression: IAV proteins are produced at the specific
phase of infection when they are needed8. One example is the M
gene, which encodes predominantly two polypeptides: the larger
protein, M1, is produced from a collinear transcript. The smaller
one, M2, is encoded by a differentially spliced transcript9. M1 is
the matrix protein with multiple functions that encapsulates the
viral genome, and also mediates nuclear export10,11. M2 is a
proton-selective channel that is an integral part of the viral
envelope12,13. The ratio of spliced to unspliced products increases
during infection14, which reflects the changing demands required
for optimal viral replication.
Systems-level approaches have provided important insights into
the molecular details of host–virus interaction15. For example,
RNA interference (RNAi) screens identified host factors required
for IAV replication16–18. Also, interaction proteomics experiments
identified many cellular binding partners of IAV proteins19–21. A
number of studies also quantified changes in protein abun-
dance22–27. However, these steady-state measurements cannot
reveal the dynamic changes in protein synthesis during different
phases of infection. Early studies used radioactive pulse labeling to
monitor protein synthesis in IAV-infected cells28,29. However,
radioactive pulse labeling cannot provide kinetic profiles for
individual proteins. More recently, stable isotope labeling by
amino acids in cell culture (SILAC) emerged as a powerful means
to study the dynamic proteome30. SILAC-based pulse labeling
methods such as pulse SILAC (pSILAC) and dynamic SILAC can
quantify protein synthesis and degradation on a proteome-wide
scale31,32. Moreover, metabolic incorporation of bioorthogonal
amino acids such as azidohomoalanine (AHA) provides a means
to biochemically enrich for newly synthesized proteins33. In
combination with SILAC, AHA labeling can be used to quantify
proteome dynamics with high temporal resolution34–36.
Here, we use metabolic pulse labeling and quantitative mass
spectrometry to compare proteome dynamics upon infection of
human cells with a human-adapted and a bird-adapted IAV
strain. We find that host proteins behave surprisingly similar, but
observe striking differences in the production of viral proteins,
especially for the matrix protein M1. Follow-up experiments with
reporter constructs, in silico studies, and reverse genetics identify
an evolutionarily conserved cis-regulatory element in the M
segment as a host range determinant.
Results
Quantifying the dynamic proteome of IAV infection. To assess
species specificity of IAVs, we used a model system comparing a
low-pathogenic avian H3N2 IAV (A/Mallard/439/2004—Mal) to
a seasonal human IAV isolate of the same subtype (A/Panama/
2007/1999—Pan). While the avian virus is not adapted to efficient
growth in cultured human cells and causes a non-permissive
infection, the seasonal human virus replicates efficiently. We
demonstrated previously that the Pan virus produces >1000-fold
more infectious viral progeny than the non-adapted virus, even
though both strains efficiently enter human cells and initiate their
gene expression program27.
We reasoned that comparing the kinetics of protein synthesis
upon infection with both strains might reveal determinants of
species specificity. To this end, we performed proteome-wide
comparative pulse-labeling experiments by combining labeling
with AHA and SILAC (Fig. 1a): cells incorporate AHA instead of
methionine into newly synthesized proteins when the cell culture
medium is supplemented with this bioorthogonal amino acid.
AHA contains an azido group, which can be used to covalently
couple AHA-containing proteins to alkyne beads via click
chemistry. In this manner, newly synthesized proteins can be
selectively enriched from the total cellular proteome. Combining
AHA labeling with SILAC reveals the kinetics of protein synthesis
with high temporal resolution36. First, we fully labeled human
lung adenocarcinoma cells (A549) using SILAC. Second,
individual cell populations were infected with either Pan or Mal
virus or left uninfected. Third, all cells were pulse labeled with
AHA for 4 h during different time intervals post infection (0–4,
4–8, 8–12, and 12–16 h). The three cell populations for every time
interval were then lysed, combined, and AHA-containing
proteins were enriched from the mixed lysate using click
chemistry (Fig. 1b). After on-bead digestion, peptide samples
were analyzed by high-resolution shotgun proteomics.
We quantified proteins using two readouts: (i) SILAC-based
relative quantification to assess differences in de novo protein
synthesis and (ii) intensity-based absolute quantification (iBAQ)
to quantify absolute amounts of newly synthesized proteins37.
Our data thus provides kinetic profiles for relative and absolute
differences in de novo protein synthesis across the course of
infection (Supplementary Data 1). In total, we identified 7729
host and 10 viral proteins and quantified 6029 proteins in at least
two biological replicates with overall good reproducibility
(Supplementary Fig. 1).
The dynamic host proteome. It is well established that IAV
induces a global reduction in the production of host proteins.
This host shutoff was attributed to a plethora of viral effector
functions38. To assess the host shutoff in our proteomic data, we
investigated iBAQ values for viral and host proteins. As expected,
viral proteins were potently induced, while the production of host
proteins decreased over time (Fig. 1c). The difference between
host and viral protein synthesis reached several orders of mag-
nitude and was highest during the 8–12 h pulse interval. More-
over, the total cellular protein output dropped to ~24% (Pan) or
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Fig. 1 A strategy to quantify protein de novo synthesis proteome-wide. a SILAC-L/M/H-labeled A549 cells were infected with the human seasonal
H3N2 IAV isolate Panama (Pan) or the avian H3N2 isolate Mallard (Mal) or left uninfected. The methionine analogous AHA was given to the methionine-
depleted medium in different 4 h intervals. b After lysis and enrichment for proteins that incorporated AHA, samples were subjected to shotgun
proteomics. Absolute and relative protein synthesis profiles were quantified for host and viral proteins. c iBAQ-based quantification of protein synthesis
levels for host and viral proteins in cells infected with either Pan or Mal virus, as indicated. Median, 25th and 75th percentile of the respective populations
are given. d Quantification of the total newly synthesized protein mass for host and viral proteins with either Pan or Mal infection as indicated. Data were
normalized to the 0–4 h time period. All data are based on the mean of n= 2 biological replicates.
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~33% (Mal) at later stages of infection, of which ~20–40% was of
viral origin (Fig. 1d). At this level of detail, we observed no major
differences between both strains. Thus, both strains initiate viral
protein synthesis and induce the shutoff of host protein synthesis
to an overall similar extent.
Next, we investigated the profiles of individual host proteins
across the course of infection. For this, we directly looked at
SILAC ratios comparing infected and non-infected cells (Fig. 2a,
b). As expected, synthesis of the vast majority of host proteins
markedly decreased over time. However, some proteins were less
affected by the host shutoff and displayed only a mildly decreased
or even increased production. To assess this observation more
systematically, we selected the proteins that were least affected by
the shutoff at different pulse periods and performed gene
ontology (GO) analysis. The heatmap of enriched GO terms
provides a global overview of biological processes as the infection
progresses (Fig. 2c and Supplementary Data 2). For example,
many well-known interferon-induced antiviral defense proteins
(e.g., MX1, several IFIT proteins, several oligoadenylate synthase
proteins) were relatively strongly produced at late stages of
infection. Also, many ribosomal proteins (GO term “peptide
chain elongation”) largely escaped the host shutoff. Interestingly,
we also observed significant enrichment of proteins involved in
steroid metabolism and mitochondrial proteins (mito-ribosomal,
respiratory chain proteins) at early and intermediate stages of
infection, respectively. Cellular responses to infection with the
Pan and Mal strain were overall similar. To assess potential
differences between permissive and non-permissive infection, we
compared protein log 2 fold changes between both viruses directly
(Fig. 2d). Interestingly, type I interferon response proteins were
first preferentially produced during non-permissive infection. At
later stages, however, infection with the Pan virus elicited a
stronger interferon response.
Several different hypotheses were made to explain the IAV-
induced host shutoff. This included mechanisms at the
transcriptional39, post-transcriptional40,41, and translational42
level. To study the relationship of mRNA and protein levels, we
quantified mRNA levels at 8 h post infection by RNA-sequencing
(RNA-seq). mRNA level differences at this time point showed
good correlation with corresponding differences in de novo
protein synthesis, particularly during the subsequent 8–12 h
period (Fig. 2e–g). Thus, mRNA level changes play an important
role for the shutoff of individual mRNAs, corroborating the view
that the host shutoff is mainly due to reduced host mRNA
levels41. The correlation was higher for the Mal than for the Pan
strain, suggesting that infection with the latter strain involves
additional post-transcriptional processes.
Traditionally, IAV is thought to prioritize the translation of
viral over host mRNAs42, but more recent experimental and
computational analyses challenge this view41,43. We investigated
this question by calculating protein synthesis efficiencies (i.e., the
amount of protein made per mRNA). To this end, we divided
iBAQ values by corresponding RPKM (Reads Per Kilobase
Million) values (Fig. 2h). Infection with both strains reduced host
protein synthesis efficiencies compared to uninfected controls.
Importantly, we did not observe preferential translation of viral
transcripts. This suggests that mRNAs from human and avian
influenza virus strains access the translational machinery with
comparable efficiency, which argues against the idea that
modulation of translation efficiency affects species specificity.
Dysregulated synthesis of viral proteins. Since the observed
differences in host protein synthesis were surprisingly subtle, we
focused our attention to the dynamics of viral protein synthesis.
Production of most viral proteins peaked in the 8–12 h period
(see Supplementary Fig. 2). The kinetics such as the early pro-
duction of NS1 and NP and delayed synthesis of M1 is consistent
with classical radioactive pulse labeling experiments29. We then
used SILAC ratios of shared peptides (i.e., peptides with sequence
identity between both strains) to precisely compare the kinetics of
viral protein synthesis (Fig. 3a, b). We found that the avian strain
produced higher amounts of all viral proteins at the beginning,
confirming that the Mal virus successfully enters cells and initi-
ates its gene expression program. Later on, during mid to
late phases, the human Pan virus produced most proteins more
abundantly than the avian strain. Note that NS1 and M2 are
excluded in this analysis because no identical peptides were
identified.
It is well established that the RdRP from avian-adapted IAV
strains is less active in mammalian cells4,44. Thus, we would have
expected the production of all viral proteins in the bird-adapted
strain to be reduced to a similar extent. In contrast, we observed
striking differences in the synthesis of individual proteins: HA
was more abundantly produced by the avian strain throughout
infection. In contrast, neuraminidase (NA) and particularly
matrix protein M1 were stronger produced by the human
strain at later stages. These differences in the production of
individual viral proteins cannot be explained by the global
difference in RdRP activity between strains. Thus, the avian strain
displays dysregulated protein production relative to its human
counterpart.
We focused our attention on the M1 protein since it showed
the largest difference between both strains. The protein is highly
conserved between Pan and Mal (~96% amino acid identity) and
the most abundant protein in virions45. Moreover, M1 is known
to mediate export of the viral genome across the nuclear
membrane—an essential step during permissive infection10,11.
Thus, accumulation of M1 at late stages of infection is required
for the appearance of viral ribonucleoproteins (vRNPs) in the
cytoplasm of infected cells. Interestingly, when investigating the
subcellular distribution of the viral nucleoprotein (NP) by
immunofluorescence microscopy, we observed efficient export
during infection with the Pan strain (Fig. 3c). In contrast, NP was
inefficiently exported and accumulated in the nucleus upon Mal
infection. These microscopy data is also corroborated by the
increased interferon response induced by the Pan strain at later
stages of infection (Fig. 2d), which is stimulated by cytosolic viral
RNA sensors46. We conclude that non-permissive infection
correlates with reduced M1 production and impaired nuclear
export of NP.
Increased M segment RNA splicing. We next sought to inves-
tigate the mechanism for the impaired M1 production. To this
end, we first quantified the levels of viral mRNAs from our RNA-
seq data. In total, the avian virus produced ~2/3 of the mRNA of
the human strain with the single largest difference observed for
M1 (Fig. 4a). The strain-specific differences in M1 mRNA levels
were very similar to the observed differences in M1 protein
production (Fig. 4b). Hence, the impaired M1 protein production
during non-permissive infection can largely be explained by
reduced M1 mRNA levels.
M1 is encoded on segment 7 (i.e., the M segment), which is the
most conserved segment between Pan and Mal (~89% nucleotide
identity). The M1 protein is produced from a collinear transcript
that can be alternatively spliced into three additional isoforms,
which all use a common 3′ splice site:47 the M2 mRNA, which
encodes the ion channel M212, RNA 3, which is not known to
encode a peptide, and M4 mRNA, which is proposed to be
translated to an isoform of the M2 ion channel in certain
strains48. We investigated the relative proportion of these
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isoforms in the RNA-seq data via splice junction reads. We
detected all known isoforms plus a yet undescribed transcript of
the avian M segment, which we call RNA 5. This transcript results
from splicing at 5′ donor GG site (pos 520/521) and the common
3′ acceptor site and contains an open reading frame in-frame with
M1 with a missing internal region (Fig. 4c).
While only a few percent (2–3%) of the M1 mRNA was
alternatively spliced during permissive infection, ~27% was
spliced upon infection with the avian strain (Fig. 4d). Thus, the
reduced level of M1 mRNA during non-permissive infection is at
least partially due to increased splicing of the M1 mRNA to
alternative isoforms. In contrast, M2 mRNA levels were rather
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similar. We note that the comparable M2 mRNA level during
non-permissive infection results from two opposing processes—
the increased splicing of the primary transcript to the M2 mRNA,
and the global reduction in viral transcripts, which is probably
due to the impaired polymerase activity4,44. We conclude that M
segment RNA splicing is markedly different in permissive vs.
non-permissive infection.
In principle, the increased splicing of the M segment RNA by
bird-adapted strains may reflect an evolutionary adaptation to
different needs of the corresponding viral proteins in avian cells.
In this case, avian-adapted strains would produce less M1 in both
human and avian cells. Alternatively, the optimal balance of viral
proteins could be constant and independent of the host species.
In this case, avian-adapted strains would produce more M1 in
avian than in human cells. To investigate this experimentally, we
infected both human and chicken cells with the Mal virus and
monitored the production of viral proteins using pSILAC (Fig. 4e).
We found that the Mal strain produced considerably more M1 in
chicken cells than in human cells (Fig. 4f). Hence, the reduced M1
production of avian viruses in human cells appears to reflect poor
adaptation to the mammalian splicing environment.
A cis-regulatory element controls M segment RNA splicing.
The differences in M1 mRNA splicing can be due to (i) cis-
regulatory elements (i.e., specific signals encoded in the M seg-
ment), (ii) trans-acting factors (i.e., other viral or host factors that
interact with M1 mRNA), or (iii) a combination of both. To
assess whether cis-regulatory elements are involved, we sought to
investigate M segment RNA splicing outside the context of
infection. We therefore designed a splicing reporter system
(Fig. 5a, b). To this end, we cloned the coding region of the M
segment (nucleotides 29–1007) into a eukaryotic expression
vector and fused it to an N-terminal Flag/HA tag. Importantly,
this construct avoids the strong 5′ splice site of RNA 349 and
enabled us to assess the relative levels of M1 to M2 proteins.
When we transfected human A549 cells with these reporter
constructs, we found that M2 was produced to high levels with
the construct containing the Mal M sequence, but was barely
detectable when the Pan M sequence was transfected (Fig. 5c).
Thus, our reporter system recapitulates splicing differences
observed during infection. We conclude that cis-regulatory ele-
ments in the M segment cause excessive splicing of the avian
variant.
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To determine the sequence responsible for the strain-specific
splicing, we made chimeric reporter constructs (Fig. 5b). When
swapping the entire intron sequence of the M2 splice variant
(nucleotides 52–739, corresponding to ~70% of the coding
sequence), we did not observe major changes in the relative
amount of M1 to M2. In contrast, integrating the human 3′ splice
site region (nucleotides 707–779, 73 nucleotides) into the avian
construct strongly impaired splicing down to the levels of the
human wild-type construct. Conversely, when we integrated the
avian 3′ splice site region into the human construct, we observed
a strong increase in splicing, similar to the avian wild-type
construct (Fig. 5c). To address splicing in the context of the viral
RdRP, we co-transfected HEK293T cells with expression vectors
for PB1, PB2, PA, and NP (of WSN strain) and Pan and Mal M
wild-type and chimeric segments. In this system, the accumula-
tion of M segment-derived mRNAs depends primarily on the
activity of the RdRP. RNA-seq revealed consistent differences in
abundance of the various isoforms with similar overall mRNA
levels (Fig. 5d). Thus, the splice site region alone is sufficient to
switch the species-specific splicing phenotype in reporter systems
using both viral and host RNA polymerases. Interestingly, this
region has been reported to contain an RNA secondary
structure50 and a binding site for the splicing factor SRSF151.
We conclude that a cis-regulatory element in the splice site region
determines the strain-specific splicing pattern.
Evolutionary conserved RNA structure elements in M segments.
We next wanted to assess whether our findings are also relevant for
other human- or bird-adapted IAVs. Specifically, we sought to
identify functionally relevant RNA secondary structures that have
been conserved during evolution of avian- and human-adapted
IAVs. To this end, we analyzed multiple sequence alignments
(MSAs) from hundreds of recent human H3N2 and avian isolates
using the RNA structure prediction program RNA-Decoder52
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(see Methods). This program is capable of dis-entangling over-
lapping evolutionary constraints due to encoded amino acids and
RNA structure features and has been shown to successfully identify
evolutionarily conserved RNA structures overlapping protein-
coding regions, for example, in viral genomes such as hepatitis C
and HIV52,53. Importantly, RNA-Decoder captures evidence on
conserved RNA structure based on the evolutionary signals enco-
ded in the sequences of the input alignment. This is a key
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advantage over computational methods that identify RNA struc-
tures based on their thermodynamic stability in vitro, as these
methods assume that the RNA has no interactions with other
molecules (e.g., proteins and other RNAs) in vivo. Also, RNA-
Decoder employs a probabilistic framework, which is capable of
estimating the reliability of its predictions.
The RNA secondary structure that is best supported by the
evolutionary signals in the two MSAs (the so-called maximum-
likelihood structure) markedly differs between human and avian
strains, particularly in the region around the 3′ splice site
(Fig. 5e): the avian region encodes a hairpin-like structure
(Fig. 5f) overlapping the 3′ splice site, which is absent from the
human-adapted sequences. This structure is similar to a hairpin
reported by Moss et al.50 for four sequences, but differs in details
(Supplementary Fig. 3). Most importantly, the evolutionarily
conserved structure reported here leaves the GC motif immedi-
ately downstream of the AG consensus at the 3′ splice site
unpaired, making it potentially more accessible to splicing. In
human-adapted sequences, this region is involved in a different
conserved secondary structure (Fig. 5e) that is mutually exclusive
with this hairpin. We conclude that the M segment of avian and
human-adapted isolates contain evolutionarily conserved RNA
secondary structures that markedly differ in exactly the region
that is critical for strain-specific splicing. Importantly, the
consensus sequences of avian and human isolates diverge by five
nucleotides in the region of interest (pos: 745, 754, 760, 766, and
772), all of which are retained with the two strains that we
investigated here (Supplementary Fig. 4A). Thus, the Pan and
Mal strains are by and large representative for human and avian
strains in this region.
In addition to these computational analyses, we also wanted to
assess RNA secondary structures experimentally. To this end, we
in vitro transcribed the region of the M segment containing
evolutionarily conserved secondary structure (nucleotides
707–825) from both strains, purified the RNA, and analyzed it
on native and denaturing agarose gels (see Fig. 5g). We observed
different migration behavior for Pan and Mal under native, but
not denaturing conditions, consistent with different secondary
structures (lanes 1 and 2). Importantly, when substituting eight
nucleotides in the region 707–779 (termed 3′ splice site region in
our manuscript) from Mal into the Pan backbone (lane 3), we
observed the same migration pattern as for the Mal wild-type
RNA. Conversely, when substituting eight nucleotides from
the Pan into Mal backbone (lane 4), we observed the same
migration pattern as for the Pan wild-type RNA.
To investigate the global significance of these findings, we
extended our analyses to other IAV isolates. The M segment of
the seasonal Pan strain originates from the M segment of the A/
Brevig Mission/1/1918 (p1918) virus, which is at the evolutionary
root of human strains and caused the 1918 “Spanish flu”
pandemic54. Therefore, we cloned the M segment of p1918 into
our reporter vector (Supplementary Fig. 4B). Again, we observed
inefficient splicing of the p1918 M gene, consistent with our data
for the Pan strain and previous reports55. Moreover, integration
the Mal 3′ splice site region into the p1918 gene increased
splicing. Thus, inefficient splicing of the M gene in human-
adapted IAVs occurs in a seasonal (Pan) and a pandemic (p1918)
strain. The M segment of the Mal strain originates from the
eastern avian lineage. A/chicken/Rostock/45/1934 (H7N1), an
early representative strain of this lineage, depicted even stronger
M segment splicing than the Mal strain (Supplementary Fig. 4C,
lane 3). Introducing the human-adapted mutations at the splice
site region into this construct completely reversed the splicing
phenotype (lane 4). Also, the “avian-like” M segment of A/swine/
Netherlands/25/1980 (H1N1) showed a splicing phenotype
similar to the Mal strain (lane 2). Finally, the human zoonotic
strain A/Vietnam/1203/2004 (H5N1) exhibited a splicing pattern
similar to the Pan strain (lane 5). Collectively, these findings
support the global significance of the strain-specific splicing
patterns with respect to host range.
The 3′ splice site region is a host range determinant. The
experiments with reporter constructs described above are
advantageous because they allow us to study the impact of M
segment sequence features in isolation. Nevertheless, it is also
important to assess the relevance of these findings during infec-
tion. We therefore mutated eight nucleotides in the splice site
region of the Pan wild-type strain to the corresponding nucleo-
tides in the Mal strain using reverse genetics (“Pan-Av” for a Pan
strain with an avian splice site region, see Fig. 6a and Supple-
mentary Data 3).
We first compared the kinetics of viral protein synthesis upon
infection of A549 cells with both strains using pSILAC31.
M1 synthesis was selectively impaired during Pan-Av infection
during both the 6–12 and 12–18 hours post infection (hpi) time
intervals. At later stages, the Pan-Av strain also showed impaired
production of other essential viral proteins (Fig. 6b), suggesting
that viral replication is also impaired. Next, we quantified M1 and
M2 protein (Fig. 6c) and mRNA levels (Fig. 6d, e). The Pan-Av
strain displayed decreased M1 protein and mRNA levels,
mimicking the behavior of the Mal strain (compare to Fig. 4).
To assess the impact of M segment splicing on IAV replication
in human cells, we assessed the growth characteristics of the
different viruses (Fig. 6f). As expected, the Pan strain reached
~1000-fold higher titers than the Mal strain. Exchanging the
entire M segment of the Pan strain with the M segment of the Mal
strain (Pan+Mal M) reduced titers about 10-fold. Importantly, a
similar ~10-fold attenuation was also seen in the Pan-Av strain,
which only differs from the Pan strain by eight nucleotides. We
conclude that the 3′ splice site of the IAV M segment is indeed an
important host range determinant.
Discussion
Advances in high-throughput sequencing have provided insights
into the extraordinary diversity of viruses and their genomic
determinants of host adaptation. However, the mechanism how
these adaptive mutations enable replication in a given host is less
understood. Our proteomic pulse labeling data allowed us to take
an unbiased look at protein synthesis upon permissive and non-
permissive infection. This is advantageous since it allows us to
investigate changes in protein synthesis with high temporal
resolution, which provides complementary information to more
classical steady-state measurements22–27. We found that the
synthesis profiles of host cell proteins were remarkably similar.
Hence, the outcome of infection does not appear to depend on a
specific host response. In contrast, we observed striking differ-
ences in the synthesis profiles of viral proteins. Particularly, the
matrix protein M1 was inefficiently produced during non-
permissive infection. Our follow-up experiments showed that
this depends— at least partially—on excessive splicing of the
avian M1 mRNA to alternative transcripts. Systematic compu-
tational analysis of the RNA structure of the M segment revealed
characteristic and evolutionarily conserved differences in the
splice site regions between human and bird-adapted strains.
Exchanging eight nucleotides in the 3′ splice site region from the
human-adapted strain to corresponding sequences in the bird-
adapted strain markedly impaired replication. Thus, our pro-
teomic analysis of IAV infection identifies M segment splicing as
a host range determinant. A hypothetical model for the influence
of M segment splicing on the IAV host range is presented in
Fig. 7.
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The cell culture-based infection model and splicing reporter
system employed here are advantageous because they enable
experiments under well-controlled conditions. Having said this, it
is important to keep in mind that these model systems do not
represent the full complexity of IAV infections in vivo. Also, the
Pan and Mal strain employed here do not represent the full
diversity of human- and bird-adapted IAVs. However, our
computational analyses show that differences in RNA secondary
structure of the 3′ splice site are widely conserved in human- and
bird-adapted IAVs. Moreover, recent results from the Steel lab
show that avian M segments restrict growth and transmission of
mammalian-adapted IAV strains in a guinea pig model56.
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Together, these findings strongly suggest that our results are also
relevant outside the specific experimental model system
employed here.
Our global assessment of protein de novo synthesis upon
infection revealed a global reduction in overall protein output
during infection with both strains, probably reflecting a global
stress response. Also, we observed the well-known shutoff of host
protein synthesis38,40,41,57. Specific classes such as interferon-
related, ribosomal and mitochondrial proteins escaped the shut-
off. We observed that the amount of protein synthesis upon
infection primarily depends on mRNA levels. Thus, altered
translation does not play a major role for the host shutoff, con-
sistent with recent findings41. Surprisingly, we also found that
viral transcripts were not more efficiently translated than host
transcripts. This contrasts with early studies based on reporter
systems57, but corroborates recent ribosome profiling data41. Our
finding is also consistent with the fact that the codon usage of
IAV genes is not optimized to reflect the codon usage of the
host43. It is also interesting that the translation efficiency of the
bird- and human-adapted strains was similarly poor. Thus,
adaptation towards high translational efficiency does not seem to
be required for crossing the species barrier.
Our unbiased proteomic analysis indicates that the differences
between permissive and non-permissive infection depend on
differences in viral rather than host protein synthesis. Hence, the
orchestrated synthesis of the viral proteome appears to be criti-
cally important for permissive infection. This supports the
emerging view that modulation of viral protein synthesis under-
pins host adaptation58. Specifically, we find that the strain-specific
differences in M1 protein synthesis critically depend on a con-
served cis-regulatory element, which controls M-segment mRNA
splicing. M1 is particularly important for the nuclear export of the
viral genome to the cytoplasm10,11. Consistently, we observed that
the genome of the bird-adapted strain was inefficiently exported
(Fig. 3c). We were not able to directly assess the role of M1 for
nuclear export because the level of ectopically expressed M1 is
much lower than the level reached during infection. Interestingly,
we also observed differences in HA and NA expression between
both strains (Fig. 3a), which may be relevant in this context.
We found that exchanging only eight nucleotides of the
human-adapted M segment to the bird-adapted sequences
markedly impaired viral replication. Hence, the cis-regulatory
element described here plays an important role for host adapta-
tion. However, it is critical to also emphasize that this is not the
only relevant factor for IAV host range. For example, despite the
overall similar host response, we and others have previously
described host factors affecting human and avian virus infec-
tions15–18,20,27. It is also well-established that the RdRP of avian-
adapted strains is less active in human cells4,44. Moreover, dif-
ferences in the binding specificity of viral HAs are known to play
an important role for host adaptation5. Lastly, M-segment spli-
cing does not only depend on cis-regulatory elements but also on
trans-acting factors, such as NS1, RdRP, NS1-BP, or
HNRNPK49,59–62. Indeed, while M1 production was clearly
impaired in our mutant strain (Fig. 6b), the wild-type bird-
adapted strain produced even less (Fig. 3a). Also, the increased
production of avian M1 in chicken cells relative to human cells
indicates that host factors play a role (Fig. 4f). It is therefore
important to interpret our findings in the broader context of viral
and host factors that jointly determine the success of IAV
replication.
We are living in a pandemic era of IAV infections that began at
around 191863. At this time, a virus of ultimately avian origin
acquired the ability to spread among humans and later on con-
tributed its genetic material to other pandemic viruses until
present. The M gene of this p1918 virus is in some regions similar
to bird-adapted sequences, but shows important signatures of
mammalian adaptation, especially at the 3′ splice site region64.
Our results suggest that mammalian adaptation at the 3′ splice
site was linked to modulating M segment RNA splicing, which
may have been relevant for the emergence of the 1918 pandemics
in humans.
Methods
Cells and viruses. A549 (ATCC CCL-185) and HEK293T (ATCC CRL-11268)
were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% (v/v) fetal bovine serum, 2 mM L-glutamine, and antibiotics. Madin–Darby
canine kidney (MDCK) type II cells (ATCC CRL-2936) were grown in minimal
essential medium supplemented with 2 mM L-glutamine and 10 % (v/v) fetal
bovine serum. DF-1 (ATCC CRL-12203) were grown in DMEM supplemented
with 10% (v/v) fetal bovine serum and 4 mM L-glutamine. All cells were main-
tained at 37 °C and 5% CO2. Stocks of the avian influenza virus A/Mallard/439/
2004 (H3N2) (Mal) (GISAID accession numbers EPI859640-EPI859647) were
grown in the allantoic cavities of 10-day-old embryonated chicken eggs for 2 days
at 37 °C. A/Panama/2007/1999 (H3N2) (Pan) (NCBI accession numbers:
DQ487333–DQ487340), Pan+Mal M reassortant and Pan-Av mutant virus were
grown in MDCK type II cells. Virus stocks were titrated on MDCK type II cells by
measuring plaque-forming units (PFUs) or fluorescence-forming units (FFUs). For
the latter, cells were infected with different dilutions of virus stock for 5 h. Then,
cells were harvested by trypsinization, fixed, and permeabilized by incubation in
75% ethanol for at least 12 h at 4 °C and stained with specific antibody against NP
antigen (clone AA5H, Bio-Rad/Serotec, 1:1000, #MCA400). An Alexa Fluor 488-
conjugated goat anti-mouse immunoglobulin G (IgG) antibody (Invitrogen) was
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Fig. 7 Hypothetical model for the role of M segment splicing for IAV host range. A cis-regulatory secondary structure element (indicated hairpins) in
avian but not human IAV M pre-mRNA facilitates splicing. This leads to the underproduction of M1 mRNA and protein in human cells infected with avian-
adapted IAVs. The poor availability of the M1 protein may contribute to an impaired nuclear export of viral ribonucleoproteins (vRNPs).
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used as secondary reagent (1:1000). Cells were analyzed on a FACSCanto II flow
cytometer (BD Biosciences) using the FACSDiva software package.
Cloning and mutagenesis. Gene fragments containing the coding sequence
(nucleotides 29–1007) of segment 7 of A/chicken/Rostock/45/1934 (GenBank
accession: CY077423), A/Vietnam/1203/2004 (GenBank accession: HM006762.1),
A/swine/Netherlands/25/1980 (GenBank accession: Z26862.1), A/BrevigMission/1/
1918 (GenBank accession: AY130766, “p1918”), a mutated A/BrevigMission/1/
1918 (with the following point mutations: C718T, A725C, A754G, G760A, G766A,
A772G, “p1918 w/ Mal 707–779”), and a mutated version of A/chicken/Rostock/
45/1934 (with the following point mutations: G712A, A714G, G740A, C745T,
G754A, A760G, “A/chicken/Rostock/45/1934 w/ Pan 707–779”) fused to attB1 and
attB2 sites were ordered as synthetic double-stranded DNA fragments from Inte-
grated DNA Technologies. The coding sequences of Pan and Mal M segments
(nucleotides 29–1007) were amplified from complementary DNA (cDNA) and
fused to attB1 and attB2 sites by PCR using the following primers:
fw_Pan: GGGGACAAGTTTGTACAAAAAAGCAGGCTCCAGCCTTCTAAC
CGAGGTCG
fw_Mal: GGGGACAAGTTTGTACAAAAAAGCAGGCTCCAGTCTTCTAAC
CGAGGTCG
rev_Pan:
GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTCCAGCTCTATGCTGA
CAAAATG
rev_Mal:
GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTCCAGCTCTATGTTGA
CAAAATG.
Cloning was done using Gateway Technology (Invitrogen) according to the
manufacturer’s protocol. Entry clones were generated from pDONR221 vector,
expression clones from pDEST26-Flag/HA destination vector. Pan/Mal chimeric
constructs were generated by replacing appropriate restriction fragments of wild-
type pDEST26-Flag/HA-Pan and pDEST26-Flag/HA-Mal, respectively, with the
corresponding synthetic chimeric DNA inserts purchased as gBlocks from
Integrated DNA Technologies.
A cDNA copy of the M segment of A/Mallard/439/2004 was amplified by RT-
PCR using the following primers:
fw: CGAAGTTGGGGGGGAGCAAAAGCAGGTAG
rev: GGCCGCCGGGTTATTAGTAGAAACAAGGTAG.
This was followed by insertion into pHW2000 resulting in pHW2000-Mal M.
The following point mutations were introduced into pHW2000-Pan M plasmid:
A712G, G714A, A740G, T745C, A754G, G760A, G766A, and A772G, creating
pHW2000-Pan-AV. The pHW2000-Mal M plasmid was mutated at the same
positions to the respective sequence of the Pan strain (G712A, A714G, G740A,
C745T, G754A, A760G, A766G, G772A, “pHW200-Mal M w/ Pan 707–779”).
Mutations were introduced using the Gibson Assembly Cloning Kit (NEB) with
pDEST26-Flag/HA-Pan w/ Mal 707–779 and the wild-type pHW2000-Pan M or
pDEST26-Flag/HA-Mal w/ Pan 707–779 and the wild-type pHW2000-Mal M as
templates for PCR. The following primers were used to amplify the insert:
fw_pDest: GAGGACTGCAGCGTAGACGCTTTG
rev_Malw/Pan_pDest: CAATGATACTTGCGGCAATAACGAGAGG
rev_Panw/Mal_pDest: CAAGATCCCAATGATACTCGCAGCAAC.
The following primers were used to amplify the backbone:
fw_Pan_pHW2000: GTTGCTGCGAGTATCATTGGGATCTTG
fw_Mal_pHW2000: CCTCTCGTTATTGCCGCAAGTATCATTG
rev_Mal/Pan_pHW2000: CAAAGCGTCTACGCTGCAGTCCTC.
All constructs were confirmed by cycle sequencing.
Reverse genetics. Recombinant IAVs derived from the A/Panama/2007/99
backbone were generated using an eight plasmid system for this strain based on
pHW2000 by transfection of human HEK293T cells, followed by passage on
MDCK type II cells. For the rescue of the Pan-Mal M reassortant virus, we used
pHW2000-Mal M, whereas the Pan-AV virus was generated with pHW2000-Pan-
AV together with seven plasmids encoding the other segments of human A/
Panama/2007/99 virus.
In vitro transcription. First, the M segment region of interest (707–825) that was
predicted to be structured was subcloned into pMCh1807_pBS_cdc42E7-boxB
(Addgene: 118612) using the primers
Mal_fw: CGATCTCGAGGTCTGAAAGATGATCTTCTTG
Pan_fw: CGATGCTCGAGTCTAAGAGATGATCTTCTTG
Mal/Pan Rev: GCTACGATCGAGTGCAAGATCCCAATG,
and fused to a T3 promoter sequence before being used as template for in vitro
transcription with the following primers:
fw: CCAAGCTCGAAATTAACCCTCACTAAAGG
rev: GCTAGCTAGCAGTGCAAGATCCCAATG.
In vitro transcription was carried out using the MegaScript Kit (Life
Technologies) according to the manufacturer’s instructions with 100 ng of template
DNA and subsequent DNA removal. The RNA was purified using phenol/
chloroform and resuspended in buffer containing 10M Tris, 100 mM KCl, 10 mM
MgCl2, and incubated at 37 °C for 30 min. To determine differences in RNA
secondary structure, RNA was run on native 1% agarose TAE (Tris-Acetate-
EDTA) gels, and then supplemented with ethidiumbromide. To denature
secondary structures, the RNA was mixed 1:5 with 65% formamide, 22% formalin,
13% 10× MOPS (3-(N-morpholino)propanesulfonic acid) buffer and incubated at
55 °C for 15 min. Then, samples were run on a denaturing MOPS agarose gel
containing 3% formalin and ethidium bromide.
pAHA-SILAC. A549 cells were fully labeled in SILAC DMEM (PAA) supple-
mented with glutamine, 10% fetal bovine serum (Life Technologies) and 2 mM L-
glutamine, antibiotics, and with either heavy (R10K8, “SILAC-H”), medium (R6K4,
“SILAC-M”), or light (R0K0, “SILAC-L”) arginine and lysine (Cambridge Isotope
Laboratories). Cells were cultured in SILAC-L/M/H medium for at least six pas-
sages. Ten-cm dishes of confluent light-labeled cells were mock-infected, while
heavy- and medium-labeled cells were infected with either Pan or Mal strain at a
multiplicity of infection (MOI) of 3 PFU (pore-forming unit). Virus was allowed to
attach to the cells for 45 min on ice. Cells were washed with pre-warmed phos-
phate-buffered saline (PBS) before the infection medium was added (SILAC
DMEM containing the respective SILAC AA, 0.2% bovine serum albumin (BSA),
2 mM glutamine, antibiotics). Prior to pulse labeling, cells were washed with pre-
warmed PBS. Methionine-depleted infection medium additionally containing
100 µM L-AHA (4-azido-L-homoalanine; Anaspec) was added for different 4-h
intervals to the cells. Cells were washed in PBS, scraped from the dish, and frozen
until further sample processing. Lysis and enrichment for newly synthesized pro-
teins was done using Click-It Protein Enrichment Kit (Invitrogen), with mod-
ifications: for the lysis, 283 µl of urea lysis buffer was used per label, samples were
incubated for 20 min on ice, sonicated and cell debris was removed before SILAC
label were mixed. Ten percent of sample was directly subjected to Wessel–Flügge
precipitation and served as the input, and 90% were used for enrichment of newly
synthesized proteins. Two hundred microliters of alkyne agarose resin was mixed
with 800 µl combined cell lysate and then catalyst solution was added. The
enrichment reactions were rotated head over tails for 18 h at room temperature.
Enriched proteins were reduced and alkylated as indicated in the manufacturer’s
instructions. Beads were then washed sequentially (each 5×) in sodium dodecyl
sulfate (SDS) wash buffer (supplied with the kit), 8 M urea in 0.1 M Tris/HCl (pH
8.0), 80% acetonitrile in 0.1 M Tris/HCl pH 8.0, and 5% acetonitrile in 50 mM
ammonium bicarbonate. Proteins were then digested in 5% acetonitrile/50 mM
ammonium bicarbonate overnight using trypsin (Promega). Peptides were then
acidified, desalted, and either directly measured on a nano LC-MS/MS setup (see
below) or subjected to isoelectric focusing using an OFFGEL fractionator.
Input samples were reduced by adding dithiothreitol (DTT) to a final
concentration of 0.1 M and incubation for 5 min at 95 °C. Sulfhydryl groups were
alkylated by adding iodoacetamide to a final concentration of 0.25 M and
incubation for 20 min in the dark at room temperature. Proteins were precipitated
according to Wessel and Fluegge, resuspended in 6M urea/2 M thiourea and
digested into peptides with C-terminal lysine or arginine using Lys-C (3 h) and
trypsin (overnight, diluted 4× with 50 mm ABC). Enzyme activity was quenched by
acidification of the samples with trifluoroacetic acid. The peptides were desalted
with C18 Stage Tips prior to nanoLC-MS/MS analysis.
pSILAC. Cells were adapted to SILAC-light medium one day before the experiment
and infected as described above using the indicated MOI. Prior to the pulse period,
cells were maintained in PBS supplemented with Ca2+/Mg2+ and 0.2% BSA for
30 min. Then, cells were pulse labeled with SILAC-M or SILAC-H medium for 6 h
intervals, harvested, and then combined. Lysis was carried out in 125 mM NaCl,
0.1% SDS, 1% NP-40, 5% glycerol, 50 mM Tris-HCl, pH 7.4 for 1 h on a rotating
wheel with subsequent centrifugation. The supernatant was precipitated according
to Wessel and Flügge and precipitated proteins were subjected to in-solution digest.
Proteins were denatured in 6M urea/2 M thiourea, reduced, alkylated, and digested
using Lys-C (3 h at 20 °C). Then, the digest solution was diluted 4× with 50 mM
ammonium bicarbonate buffer and incubated with trypsin (Promega) for 16 h at
20 °C. Afterwards, samples were acidified and subjected to stage tip purification.
Mass spectrometry. Peptides from input and AHA-enriched samples were
separated on a monolithic silica capillary column (MonoCap C18 High-Resolution
2000, GL Sciences), 0.1 mm internal diameter × 2000 mm length, at a flow rate of
300 nl/min with a 5 to 45% acetonitrile gradient on an EASY-nLC II system
(Thermo Fisher Scientific) with 480 or 240 min gradient or on a EASY-nLC HPLC
(Thermo Fisher) system by 2 or 4 h gradients with a 250 nl/min flow rate on a
15 cm column with an inner diameter of 75 μm packed in-house with ReproSil-Pur
C18-AQ material (Dr. Maisch, GmbH). Peptides were ionized using an ESI source
on a Q-Exactive, Q-Exactive Plus or a LTQ (linear trap quadrupole) Orbitrap Velos
MS (all Thermo Fisher) in data-dependent mode. Q-Exactive and Q-Exactive Plus
mass spectrometers were operated in the data-dependent mode with a full scan in
the Orbitrap, followed by top 10 MS/MS scans using higher-energy collision dis-
sociation. The full scans were performed with in a m/z range of 300–1700, a
resolution of 70,000, a target value of 3 × 106 ions and a maximum injection time of
20 ms. The MS/MS scans were performed with a 17,500 resolution, a 1 × 105 target
value, and a 60 ms maximum injection time. The LTQ Orbitrap Velos instrument
was operated in data-dependent CID top 20 mode. Full scans were performed in
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m/z range 300–1700 with a resolution of 60,000 and a target value of 106. MS/MS
scans were performed with an isolation window of 2m/z and a target value of 3000.
Peptides from pSILAC samples were separated by 4 h gradients and ionized
with ESI source and analyzed on Q-Exactive HF-X instrument (Thermo Fisher) in
data-dependent mode. The full scans were performed with a resolution of 60,000, a
target value of 3 × 106 ions and a maximum injection time of 10 ms. The MS/MS
scans were performed with a 15,000 resolution, a 1 × 105 target value and a 22 ms
maximum injection time.
Data analysis. Raw files of the pAHA-SILAC were analyzed with MaxQuant
software version 1.6.0.1 Default settings were kept, except that “requantify” option
was turned on. Label-free quantification via iBAQ calculation was enabled. Lys4/
Arg6 and Lys8/Arg10 were set as labels and oxidation of methionines, n-terminal
acetylation, and deamidation of asparagine and glutamine residues were defined as
variable modifications. The in silico digests of the human Uniprot database
(downloaded January 2018), the protein sequences of 12 Pan and Mal Influenza
virus proteins and a database containing common contaminants were done with
Trypsin/P. The false discovery rate was set to 1% at both the peptide and protein
level and was assessed by parallel searching a database containing the reverted
sequences from the Uniprot database. The resulting text files were filtered to
exclude reverse database hits, potential contaminants and proteins only identified
by site (i.e., protein identifications that are only explained by a modified peptide).
Plotting and statistics were done using R and figures were compiled in Illustrator
(Adobe). Raw files for pSILAC were analyzed as described above, except that
MaxQuant software version 1.5.2.8 was used. For the pSILAC experiment com-
paring Mal infection in human and avian cells, spectra were searched against a
database additionally containing the uniprot entries of gallus gallus. For the pSI-
LAC experiment comparing Pan and Pan-AV, requantify option was set to off.
Proteomic data processing. Two MaxQuant output files were used: pro-
teinGroups.txt and evidence.txt. iBAQ values from infected samples were extracted
from proteinGroups.txt. iBAQ values were first normalized by scaling to the iBAQ
protein median across all mock-infected samples. This assumes that there are no
differences in overall protein synthesis for different mock-infected samples. The
iBAQ values were averaged for the corresponding label-swap replicates and pro-
teins were categorized as host or viral. For estimating the newly synthesized protein
mass, intensity values of H and M SILAC channels were divided by the summed up
intensities of the light channel (mock infected). Data were then averaged for label-
swap replicates and summed up for viral and host proteins independently. Finally,
data were normalized to the 0–4 h time period.
SILAC ratios of host proteins were processed by first transforming them into
log 2 space. The median SILAC-H/L and SILAC-M/L ratios from the input samples
were used to estimate the mixing ratio of the input and the H/L and M/L ratios
after the enrichment were adjusted correspondingly. SILAC-H/M ratio that relate
to the Pan/Mal (or Mal/Pan) infection treatment were normalized to 0. Then, the
replicate measurements were averaged. Proteins that were quantified in only one
replicate were excluded. Later the top 2% of proteins (highest log2 fold-change) of
either Pan/Mock or Mal/Mock condition were selected and multi-set GO
enrichment was performed using Metascape tool (http://metascape.org).
Protein level data was matched to RNA level data based on the HGNC official
gene symbol. Protein synthesis efficiencies were calculated by subtracting log 10
(RPKM) from log 10(iBAQ) values.
For quantification of pAHA-SILAC viral protein expression kinetics, we
extracted all quantifications of peptide level evidences for each individual replicate
from evidence.txt. Median log 2 ratios were then normalized to 0 for individual
replicates. Comparative viral protein expression kinetics were based on Pan/Mal
shared peptides. For each time period, replicate, and viral protein, the Pan/Mal
SILAC protein ratio was calculated as the median of all SILAC peptide level ratios.
Replicate SILAC protein ratios were averaged. For pSILAC, ratios for viral proteins
were extracted from proteinGroups.txt. Non-normalized and log-2-transformed
ratios were used.
RNA-sequencing and data processing. Total RNAs from A549 cells infected with
Pan or Mal strain (infection conditions as described in the pAHA-SILAC experi-
ment) were extracted using TRIzol reagent (Life Technologies) following the
manufacturer’s protocol. Truseq Stranded mRNA sequencing libraries were pre-
pared with 500 ng total RNA according to the manufacturer’s protocol (Illumina).
The libraries were sequenced on HiSeq 2000 platform (Illumina) and yielded in
total 186 million 101-nt single-end reads. The sequencing reads were first subjected
to adapter removal using flexbar with the following parameters: -x 6 -y 5 -u 2 -m 28
-ae RIGHT -at 2 -ao 1 -n 4 -j -z GZ65. Reads mapped to the reference sequences of
rRNA, tRNA, snRNA, snoRNA and miscRNAs (available from Ensembl and
RepeatMasker annotation) using Bowtie2 (version 2.1.0) with default parameters
(in --end-to-end & --sensitive mode) were excluded. The remaining reads were
then mapped to the human and Pan/Mal influenza A reference genome using
Tophat2 (v2.0.10) with parameters: -N 3 --read-gap-length 2 --read-edit-dist 3
--min-anchor 6 --library-type fr-firststrand --segment-mismatches 2 --segment-
length 26, and the guidance of RefSeq/Ensembl human gene structure and known
viral gene annotation. Gene expression levels (RPKM) were estimated by Cufflinks
(v2.2.1) with parameters: -u --library-type fr-firststrand --overhang-tolerance 6
--max-bundle-frags 500000000. Splice junction reads for various M transcripts
were counted with customized Perl scripts. Splice isoforms were accepted that had
>500 read counts in both replicates. The same RNA-seq experimental and com-
putational procedures were applied to samples that were transfected, as well as the
Pan-AV and the control wild-type infection samples (Pan), except that HiSeq 4000
platform (Illumina) was used and that libraries were sequenced in the 2 × 151-nt
paired-end mode.
To account for differences in transfection efficiency and sequencing depth from
transfected samples, we calculated a scaling factor for NP, PA, PB1, and PB2 across
all experiments based on their FPKM expression values. The splice junction read
count was then divided by the average of the scaling factors.
Transfections. A549 cells were seeded on 6-well plates and transfected with 2.5 µg
of expression constructs and Lipofectamine 3000 (Thermo Fisher) reagent
according to the manufacturer’s instructions. Cells were harvested by trypsinization
and subjected to lysis and immunoblotting. For the RdRP reporter experiment,
10 cm dishes of HEK293T cells were transfected with vectors encoding NP (4.5 µg),
PA (1.5 µg), PB1 (1.5 µg), or PB2 (1.5 µg) of strain WSN and either pHW2000-Mal
M, pHW2000-Pan M pHW2000-Pan-AV, or pHW200-Mal M w/ Pan 707–779
(0.75 µg) using polyethyleneimine. Half of the sample was subjected to RNA iso-
lation and RNA-sequencing 24 h post transfection.
Lysis, SDS-polyacrylamide gel electrophoresis, and immunoblotting. Cells
were lysed in lysis buffer (125 mM NaCl, 0.1% SDS, 1% NP-40, 5% glycerol, 50 mM
Tris-HCl, pH 7.4) for 1 h on a rotating wheel and centrifuged. Supernatant was
supplemented with NuPage LDS Sample buffer (Invitrogen), 50 mM DTT, and
heated for 10 min at 70 °C. Samples were run on 4–12% Bis-Tris gradient gels
(NuPAGE, Invitrogen) before being blotted onto PVDF membrane (Immobilon-P,
Millipore) using a wet blotting system (Invitrogen). Specific antibodies against the
HA epitope (clone 3F10, Roche, 1:500, #11867423001), vezatin (clone B-1, Santa
Cruz, 1:1000, #sc271347), M1 (clone GA2B, Bio-Rad, 1:1000, #MCA401) or M2
(polyclonal, RRID: AB_2549706, Thermo Fisher, 1:1000, #PA5-32233) and suitable
horseradish peroxidase-linked secondary antibodies were used. See source data file
for raw blot images.
Immunofluorescence microscopy. A549 cells were grown on glass coverslips and
infected with the indicated viruses at an MOI of 1 FFU (fluorescence-forming
unit)/cell. At the indicated time points post infection, cells were fixed for 15 min in
2.5% formaldehyde, permeabilized in 0.2% Triton X-100, and stained with specific
antibody against NP antigen (clone AA5H, Bio-Rad/Serotec, 1:1000, #MCA400) in
3% BSA for 1 h. After washing, cells were stained with Alexa Fluor 488-conjugated
goat anti-mouse IgG secondary antibody (1:1000) in 3% BSA. Nuclei were coun-
terstained with 4′,6-diamidino-2-phenylindole (DAPI) by adding to the secondary
antibody solution. Coverslips were mounted using Mowiol and images were
acquired by an Eclipse A1 laser-scanning microscope using the NIS-Elements
software package (Nikon). At least 140 cells were counted per condition to quantify
the subcellular distribution of NP using the ImageJ software.
Computational RNA structure analyses. M segment sequences were obtained
from the NIAID Influenza Research Database (IRD) through the website at http://
www.fludb.org. We used the following settings for human-adapted strains: date
range ≥2009, subtype H3N2, only complete genomes, host human; exclude
laboratory strains and duplicate sequences and geographic grouping: South
America, Europe, and Asia; for avian-adapted strains: date range ≥2009, only
complete genomes, host: avian; exclude duplicate sequences and geographic
grouping: Europe and Asia. These two sets of sequences were merged with the
respective references sequence, that is, A/Panama/2007/1999—Pan (human) and
A/Mallard/439/2004—Mal (mallard), and aligned using the program Muscle66
resulting in two MSAs, one for the human-adapted strains comprising
403 sequences and one MSA for the avian-adapted strains comprising
199 sequences. Both alignments are straightforward to establish based on the long
open reading frame of the M1 isoform covering almost all of the M segment and on
the overall high primary sequence conservation of the M segment. Evolutionary
trees relating the sequences in either MSA were then derived using PhyML in
conjunction with the HKY evolutionary model, which provided the best fit to the
data [version v3.067].
These two input alignments (including the combined annotation of the known
protein-coding M1 and M2 regions) and the corresponding evolutionary trees were
then used as input to RNA-Decoder52. We used RNA-Decoder to identify the RNA
secondary structure that is best supported by the evolutionary signals contained in
the two input alignments (the so-called maximum-likelihood structure). The
predictions by RNA-Decoder also included the posterior base-pairing probabilities
for each base pair of the predicted RNA structure. Predicted base pairs with a base-
pairing probability smaller than 25% were omitted from the RNA structure
visualization. Note that each multiple sequence alignment was analyzed by RNA-
Decoder in one chunk, that is, without partitioning it artificially into sub-
alignments.
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Finally, the predicted RNA structure element nucleotides 733–766 was plotted
with the sequence of the Mal strain using VARNA tool68 and the RNA structures
predicted for the two alignments of avian- and human-adapted sequences was
visualized using R-chie69, including information on the pairing probability of each
base pair.
Nucleotide-level conservation. To retrieve M segment consensus sequences for
human and avian-adapted strains, we used the NIAID IRD70 through the website
at http://www.fludb.org (downloaded 10 July 2018). The following options were
applied to retrieve avian-adapted consensus sequences: date range: 1999–2011,
complete genome, minimum length M segment sequence 1027, and exclude
duplicated and laboratory strains. The following options were used to retrieve the
human consensus: date range: 1999–2011, complete genome, minimum length M
segment sequence 1002, and exclude duplicated and laboratory strains.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Proteomic data relating to the pAHA-SILAC and pSILAC experiments was uploaded to
ProteomeXchange Consortium via the PRIDE partner repository with the dataset
identifier PXD011321 (pAHA-SILAC) and PXD015475, PXD015474 (pSILAC) RNA-
sequencing data is publicly available under PRJNA495615 [https://www.ncbi.nlm.nih.
gov/sra/PRJNA495615]. The source data underlying Figs. 1c, d, 2a–d, f–h, 3a, d, 4a, b, d,
f, 5c–g, 6b–f and Supplementary Figs. 2 and 4a–c are available as Source Data file.
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